Saturday 17 October 2026 Export HRMY’s income statement to Excel — free account

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024. In the quarter to June 2026, revenue grew 30.3%, EPS grew 88.4%, free cash flow grew 16.5% and total debt fell 10.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

38.20 0.07 −0.18%

Follow HRMY

Alert me

Market cap: $2.2B
P/E: 12.2×
Fwd P/E: 9.4×
Dividend yield: —
F-score: 5/9
Altman Z: 5.23
Beneish M: −2.99
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	11.63	11.12	13.61	8.53	+8 more quarters Free account
P/S ratio Full definition →	2.20	1.80	2.48	1.92
P/FCF ratio Full definition →	6.70	5.37	6.99	6.17
P/Operating CF Full definition →	22.82	58.34	17.05	14.59
P/B ratio Full definition →	2.11	1.78	2.47	1.90
Price to Tangible BV Full definition →	2.29	1.96	2.76	2.14
EV/Sales Full definition →	1.66	1.27	1.77	1.31
EV/EBITDA Full definition →	6.25	5.31	6.61	4.36
EV/Operating CF Full definition →	4.49	3.33	4.42	3.64
EV/FCF Full definition →	5.07	3.77	5.00	4.21
Quick Ratio Full definition →	3.33	3.45	3.46	3.46
Current Ratio Full definition →	3.48	3.58	3.60	3.75
Net Debt/EBITDA Full definition →	(5.41)	(11.16)	(13.34)	(7.07)
Debt/Assets Full definition →	11.21%	12.49%	12.87%	13.95%
Debt/Equity Full definition →	0.15	0.17	0.19	0.20
Asset Turnover Full definition →	0.77	0.77	0.76	0.77
Operating CF/Net income Full definition →	1.23	0.85	5.61	2.14
Capex/Depreciation Full definition →	0.00	0.00	(0.01)	(0.01)
Interest Coverage Full definition →	29.09	11.53	10.87	18.09
Research and Development Expense of Revenue Full definition →	17.83%	32.21%	20.48%	22.95%
Selling, General and Administrative Expense of Revenue Full definition →	23.79%	29.81%	35.58%	24.79%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.07	0.08
Share Based Compensation of Revenue Full definition →	3.57%	4.93%	4.09%	4.58%
Graham Net Nets Full definition →	0.21	0.26	0.24	0.29
Graham Number Full definition →	34.85	29.88	30.60	32.47
Earnings Yield Full definition →	8.60%	9.00%	7.35%	11.72%
Free Cash Flow Yield Full definition →	14.92%	18.63%	14.31%	16.20%
Revenue per Share Full definition →	4.51	3.73	4.24	4.16
Operating CF per Share Full definition →	1.60	0.48	2.19	1.89
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	1.60	0.48	2.19	1.89
Cash per Share Full definition →	11.53	11.08	13.49	11.69
Shareholders Equity per Share Full definition →	17.25	15.74	15.14	14.51
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	17.25	15.74	15.14	14.51
Free Cash Flow Full definition →	92.43	27.76	126.04	108.66
Working Capital Full definition →	580.26	561.48	654.88	615.40
Capital Expenditures Full definition →	—	—	(0.11)	(0.07)
Net Current Asset Value Full definition →	440.49	417.34	505.60	465.71
EV/EBIT Full definition →	6.92	6.00	7.39	4.80
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	9.15	8.55	10.32	7.03
Other line items
Average Receivables Full definition →	101.99	107.10	89.91	91.08
Average Payables Full definition →	24.99	23.03	15.72	18.44
Average Inventory Full definition →	6.23	5.83	6.28	6.90
Average Assets Full definition →	1,240.55	1,163.68	1,135.42	1,068.18
Average Common Equity Full definition →	886.16	815.44	764.69	715.96

Fold the line items

Columns are period end dates

Stockrow Weekly